石四药集团：吗啉硝唑获国家药监局批准登记成为在上市制剂使用的原料药

Core Viewpoint - The company Shijiazhuang Fourth Pharmaceutical Group has received approval from the National Medical Products Administration of China for its raw material drug, Metronidazole, to be used in marketed formulations [1] Group 1 - Metronidazole is a nitroimidazole antibiotic primarily used for treating anaerobic bacterial infections such as appendicitis and pelvic inflammatory disease [1]